Travere Therapeutics, Inc. · NASDAQ:TVTX

Coughlin Timothy received 4,000 Travere Therapeutics, Inc. shares as an award (Form 4)

Traded May 19, 2026 · Filed May 21, 2026

On May 19, 2026, Coughlin Timothy (Director) received 4,000 Travere Therapeutics, Inc. shares as an award, leaving 56,250 shares. Filed May 21, 2026 (Form 4).

Awarded
4,000 shares
Holding after
56,250 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 19, 2026Common StockAward4,00056,250Direct

Source

View original at SEC

Related